Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions.

@article{Mcduffie2002ThreemonthTO,
  title={Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions.},
  author={Jennifer R Mcduffie and Karim Anton Calis and Gabriel Ikponmosa Uwaifo and Nancy G. Sebring and Erica M. Fallon and Van S. Hubbard and Jack A. Yanovski},
  journal={Obesity research},
  year={2002},
  volume={10 7},
  pages={642-50}
}
OBJECTIVE To study the safety, tolerability, and potential efficacy of orlistat in adolescents with obesity and its comorbid conditions. RESEARCH METHODS AND PROCEDURES We studied 20 adolescents (age, 14.6 +/- 2.0 years; body mass index, 44.1 +/- 12.6 kg/m(2)). Subjects were evaluated before and after taking orlistat (120 mg three times daily) and a multivitamin for 3 months. Subjects were simultaneously enrolled in a 12-week program emphasizing diet, exercise, and strategies for behavior… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Similar Papers

Loading similar papers…